Dr. Jay Keasling discusses the promise of engineering microbes to create carbon-neutral products for a range of applications, including fuels, chemicals, and drugs. Keasling discusses the application of engineering microbes to the development of a microbial platform for the synthesis of the anti-malarial drug, artemisinic acid. This platform has helped stabilize the global supply. He also discusses additional applications of engineering microbes to fuel production, as well as some of the current challenges and possible solutions facing the metabolic engineering community.
Jay Keasling is a Professor of Chemical engineering and Bioengineering at the University of California, Berkeley, an Associate Laboratory Director for Biosciences at Lawrence Berkeley National Laboratory, and also chief executive officer of the Joint BioEnergy Institute (JBIE). He received his PhD in Bernhard Palsson’s lab at University of Michigan and was a post-doc with… Continue Reading